Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Int J Lab Hematol ; 38(3): 223-32, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26993054

ABSTRACT

UNLABELLED: Hemoglobinopathies are the most common genetic disease in Tunisia with a total carrier prevalence of 4.48%. OBJECTIVE: The aim of this study was to report an 18-year fully achieved experience of prenatal diagnosis (PND) of hemoglobinopathies (1994-2012) and to assess the impact of this prevention program. PATIENT AND METHODS: A total of 461 fetuses of 340 at-risk couples have been the subject of PND for beta-thalassemia major risk (41%), for sickle cell anemia risk (40.3%), for S/beta-thal risk (14.7%). The remainder fetuses were at risk for a compound heterozygote hemoglobinopathies (S/O, O/beta-thal, S/C….). Fetal DNA was studied by PCR procedure including the reverse dot-blot technique and the amplification refractory mutation system and direct sequencing. RESULTS AND DISCUSSION: Only 13.8% of the fetal samplings were conducted by chorionic villus sampling. The molecular result for beta-thalassemia risk has shown 13 beta-thal mutations, with two common: codon 39 (C>T) and IVS1-110 (G>A). The last 3 years, STR study has permitted to reduce the problems of maternal cell contamination. Among the 461 tested fetuses, 121 were affected, and then the pregnancy was terminated except for 13 cases, because of religious considerations and this despite the abortion legality in Tunisia. The conducted PND is only about 30 PND per year corresponding essentially to the couples living in Tunis City and surrounding area. PND number has increased from 1994 to 2009. This evolution has brutally decreased after the Tunisian revolution (2010). CONCLUSION: Although the good running of the PND, it covers only the Tunis city with low impact because it prevent apparition of only a mean of 7.3% of new cases. The reduced number of PND is not a technical inconvenience but rather a lack of a preventive program.


Subject(s)
Anemia, Sickle Cell/diagnosis , Fetal Diseases/diagnosis , Prenatal Diagnosis/methods , beta-Thalassemia/diagnosis , Anemia, Sickle Cell/epidemiology , Anemia, Sickle Cell/genetics , Female , Fetal Diseases/epidemiology , Fetal Diseases/genetics , Humans , Male , Polymerase Chain Reaction , Pregnancy , Prenatal Diagnosis/instrumentation , Retrospective Studies , Tunisia , beta-Thalassemia/epidemiology , beta-Thalassemia/genetics
2.
Rev Neurol (Paris) ; 172(2): 127-31, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26563666

ABSTRACT

BACKGROUND: Alzheimer's disease (AD) is a progressive neurodegenerative disorder with an as yet poorly understood etiology. Both environmental and genetic factors have been implicated as predisposing factors. The apolipoprotein E (APOE) ɛ4 allele is an established genetic susceptibility factor for AD for several populations including the Tunisian population. Polymorphism rs769446 (-427 T/C) at the promoter region of the APOE gene is postulated to affect the expression of the gene through differential binding of transcription factors. AIMS: This study aims at examining the APOE promoter polymorphism rs769446 for possible association with AD in a Tunisian population. METHODS: Using a case-control study design, a sample of 85 patients and 90 controls were investigated for association with the rs769446 polymorphism. RESULTS: No evidence of association was found in this population upon comparison between patients and healthy controls or upon stratification by APOE É›4. CONCLUSIONS: Investigations of potential gene-gene and gene-environmental interactions for this polymorphism need to be further conducted.


Subject(s)
Alzheimer Disease/genetics , Apolipoprotein E4/genetics , Polymorphism, Single Nucleotide , Promoter Regions, Genetic/genetics , Aged , Aged, 80 and over , Case-Control Studies , Female , Genetic Association Studies , Genetic Predisposition to Disease , Humans , Male , Middle Aged , Tunisia
3.
Pathol Biol (Paris) ; 63(4-5): 169-74, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26358851

ABSTRACT

PURPOSE: Determining the frequency of M470V polymorphism in cystic fibrosis and healthy cohort in Tunisia to establish the contribution of M470V polymorphism in cystic fibrosis variable presentation and course. Additionally, studying the origin of cystic fibrosis transmembrane conductance regulator gene in Tunisian population and its evolution among populations worldwide. PATIENTS AND METHODS: The genotyping of M470V marker was realized by PCR-RFLP technique in 34 unrelated patients and 50 healthy subjects. RESULTS: Statistical difference was found in the genotype and allelic distribution between CF and control groups. Exclusive association between F508del allele and M470 allele was noted. CONCLUSION: This study has contributed to better understanding involvement of the M470V polymorphism in the CF clinical expression in the Tunisian population and has confirmed the utility of this marker in the study of the origin and evolution of the CFTR locus in the human history.


Subject(s)
Amino Acid Substitution , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Cystic Fibrosis/genetics , Mutation, Missense , Point Mutation , Alleles , Child , Child, Preschool , Cystic Fibrosis/ethnology , Ethnicity/genetics , Female , Founder Effect , Gene Frequency , Genetic Predisposition to Disease , Genotype , Haplotypes/genetics , Humans , Infant , Infant, Newborn , Male , Tunisia/epidemiology , White People/genetics
4.
Pathol Biol (Paris) ; 63(4-5): 175-8, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26277914

ABSTRACT

PURPOSE: In this work, we are interested to study the implication of -509C/T polymorphism, located in the promoter region of TGFB1 (transforming growth factor ß1), in the phenotypic variability of CF patients. PATIENTS AND METHODS: The present study enrolled 111 CF patients and 100 healthy control subjects. The study of the -509C/T polymorphism was performed using PCR-RFLP method. RESULTS: We found that patients carried non-F508del homozygous mutation with TT genotype was associated to lung symptoms (P=0.04). This association was not found in the sub-groups of patients with F508del at homozygous state P=0.145. No association was found between this polymorphism and the variability of digestive, pancreatic and ileus meconial symptoms. CONCLUSION: On the basis of our results, the -509C/T polymorphism of the TGFB1 gene seems to be a modulator factor of cystic fibrosis.


Subject(s)
Cystic Fibrosis/genetics , Polymorphism, Single Nucleotide , Transforming Growth Factor beta1/genetics , Adolescent , Adult , Case-Control Studies , Child , Child, Preschool , Cystic Fibrosis/complications , Cystic Fibrosis/pathology , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Diabetes Mellitus/etiology , Digestive System Diseases/etiology , Female , Humans , Ileus/etiology , Infant , Infant, Newborn , Male , Meconium , Pancreatitis/etiology , Phenotype , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length , Promoter Regions, Genetic/genetics , Respiratory Insufficiency/etiology , Young Adult
5.
Pathol Biol (Paris) ; 63(3): 126-9, 2015 Jun.
Article in English | MEDLINE | ID: mdl-26002249

ABSTRACT

PURPOSE: We present in this study our 10years experience in prenatal diagnosis of cystic fibrosis performed in the Tunisian population. PATIENTS AND METHODS: Based on family history, 40 Tunisian couples were selected for prenatal diagnosis. Fetal DNA was isolated from amniotic fluid collected by transabdominal amniocentesis or from chronic villi by transcervical chorionic villus sampling. The genetic analysis for cystic fibrosis mutations was performed by denaturant gradient gel electrophoresis and denaturing high-pressure liquid phase chromatography. We performed microsatellites analysis by capillary electrophoresis in order to verify the absence of maternal cell contamination. RESULTS: Thirteen fetuses were affected, 21 were heterozygous carriers and 15 were healthy with two normal alleles of CFTR gene. Ten couples opted for therapeutic abortion. The microsatellites genotyping showed the absence of contamination of the fetal DNA by maternal DNA in 93.75%. CONCLUSION: Our diagnostic strategy provides rapid and reliable prenatal diagnosis at risk families of cystic fibrosis.


Subject(s)
Amniocentesis , Chorionic Villi Sampling , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Cystic Fibrosis/diagnosis , Abortion, Eugenic , Alleles , Arabs/genetics , Chorionic Villi Sampling/adverse effects , Chromatography, High Pressure Liquid , Cystic Fibrosis/embryology , Cystic Fibrosis/epidemiology , Cystic Fibrosis/genetics , Cystic Fibrosis Transmembrane Conductance Regulator/analysis , Diseases in Twins/diagnosis , Diseases in Twins/genetics , Electrophoresis, Polyacrylamide Gel , Female , Fetal Death/etiology , Genetic Counseling , Genotype , Humans , Male , Microsatellite Repeats , Pregnancy , Pregnancy, Twin , Retrospective Studies , Tunisia/epidemiology
6.
Acta Physiol Hung ; 102(1): 86-93, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25481366

ABSTRACT

The analysis of some extra- and intragenic markers within or closely linked to the cystic fibrosis transmembrane regulator (CFTR) gene is useful as a molecular method in clinical linkage analysis. Indeed, knowing that the molecular basis of cystic fibrosis (CF) is highly heterogeneous in our population, the study of haplotype association with normal and CF chromosomes could be very helpful in cases where one or both mutations remain unidentified. In this study, we analysed with PCR-RFLP and capillary electrophoresis some extra (pJ3.11, KM19 and XV2C) and intragenic (IVS8CA, IVS17bTA and IVS17bCA) polymorphic markers in 50 normal and 10 Tunisian patients carrying the rare E1104X mutation in order to determine the haplotype associated with this mutation. For the extragenic markers, 8 haplotypes were identified. The most frequent of them are the 221 and 112 accounting for 80% of total haplotypes. For the intragenic markers, five haplotypes were present on the E1104X chromosomes. One of them 16-31-13 accounted for 50%. To our knowledge, this is the first work to be interested to the haplotypes linked to the E1104X mutation. This preliminary study of haplotypes could be a helpful method to determine the molecular lesions responsible of this pathology.


Subject(s)
Cystic Fibrosis/genetics , Genetic Predisposition to Disease/genetics , Haplotypes/genetics , Child, Preschool , Cystic Fibrosis/epidemiology , Female , Genetic Markers/genetics , Genetic Predisposition to Disease/epidemiology , Humans , Infant , Male , Mutation/genetics , Pilot Projects , Polymorphism, Single Nucleotide/genetics , Prevalence , Tunisia/epidemiology
7.
Mol Biol Rep ; 40(11): 6205-12, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24065537

ABSTRACT

Beta-thalassemia is the most frequent hereditary blood disorder in Tunisia because of its geographic localization and history. This pathology is characterized by a complex multisystem process with genetic and biochemical interactions. The aim of this work was to establish phenotype/genotype association through studying the distribution and the relationship between ß-thalassemia and α-thalassemia mutations and three polymorphic markers: the C → T polymorphism at -158 of the Gγ gene, the RFLP haplotype and the repeated sequence (AT)xTy in the ß globin silencer, in two groups of ß-thalassemia major and ß-thalassemia intermedia (TI) patients. Statistical analysis has shown that moderate expression seen in TI patients was significantly associated to ß(+) -87 (C → G), -30 (T → A) and IVSI-6 (T → C) mutations, haplotypes VIII, IX and Nb and to XmnI polymorphism. The regression analysis of combined genotypes (mutation/XmnI/RFLP haplotype) revealed that they contribute to justify 17.1 % of clinical expression diversity (p < 0.05). Among the studied genotypes the XmnI polymorphism seems to be the most determinant modulating factor, followed by the ß-thalassemia mutation and RFLP haplotype. Our findings highlight the heterogeneity of molecular background of ß-thalassemia that would be responsible of clinical variability.


Subject(s)
Genetic Association Studies , Genetic Heterogeneity , beta-Globins/genetics , beta-Thalassemia/diagnosis , beta-Thalassemia/genetics , Adolescent , Adult , Child , Child, Preschool , Gene Order , Haplotypes , Hemoglobins/genetics , Hemoglobins/metabolism , Humans , Middle Aged , Mutation , Nucleotide Motifs , Phenotype , Polymorphism, Genetic , Polymorphism, Restriction Fragment Length , Promoter Regions, Genetic , Tunisia , Young Adult , alpha-Thalassemia/genetics , alpha-Thalassemia/metabolism , beta-Thalassemia/blood , gamma-Globins/genetics
8.
Mol Biol Rep ; 40(2): 851-6, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23065279

ABSTRACT

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzyme defect. In this study, we aimed to perform a molecular investigation of G6PD deficiency in Tunisia and to associate clinical manifestations and the degree of deficiency with the genotype. A total of 161 Tunisian subjects of both sexes were screened by spectrophotometric assay for enzyme activity. Out of these, 54 unrelated subjects were selected for screening of the most frequent mutations in Tunisia by PCR/RFLP, followed by size-based separation of double-stranded fragments under non-denaturing conditions on a denaturing high performance liquid chromatography system. Of the 56 altered chromosomes examined, 75 % had the GdA(-) mutation, 14.28 % showed the GdB(-) mutation and no mutations were identified in 10.72 % of cases. Hemizygous males with GdA(-) mutation were mostly of class III, while those with GdB(-) mutation were mainly of class II. The principal clinical manifestation encountered was favism. Acute hemolytic crises induced by drugs or infections and neonatal jaundice were also noted. Less severe clinical features such as low back pain were present in heterozygous females and in one homozygous female. Asymptomatic individuals were in majority heterozygote females and strangely one hemizygous male. The spectrum of mutations seems to be homogeneous and similar to that of Mediterranean countries; nevertheless 10.72 % of cases remain with undetermined mutation thus suggesting a potential heterogeneity of the deficiency at the molecular level. On the other hand, we note a better association of the molecular defects with the severity of the deficiency than with clinical manifestations.


Subject(s)
Glucosephosphate Dehydrogenase Deficiency/genetics , Glucosephosphate Dehydrogenase/genetics , Mutation, Missense , Adolescent , Adult , Amplified Fragment Length Polymorphism Analysis , Child , Child, Preschool , DNA Mutational Analysis , Female , Gene Frequency , Genetic Association Studies , Heterozygote , Humans , Male , Tunisia , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...